The rule, released Thursday, builds on Trump administration’s priorities, including cutting Medicare reimbursement for drugs ...
Objective Recent advances in giant cell arteritis (GCA) management aim to reduce glucocorticoid (GC). We described changes in ...
Changes will go into effect Jan. 1, 2027, and aim to improve care delivery and data for maternal health outcomes.
The FDA has declined to approve Sobi’s investigational infusion of nanoencapsulated sirolimus plus pegadricase for adults ...
The Trump administration is closing a loophole that drugmakers could use to avoid negotiations when they add active ...
This episode, titled 'NCCN Guidelines in Focus: Key Updates for Follicular Lymphoma and Their Impact on Formulary Decisions,' features Ryan Haumschild, PharmD, MS, MBA, CPEL discussing the following ...
An AI program in the state of Utah has sparked a vigorous debate about the role of the technology in health care.
Minhee Kang, PharmD, discusses 3 key considerations for oncology pharmacists to improve treatment safety, patient education, ...
An analysis of the June 2026 final rulemaking that updated the federal independent dispute resolution (IDR) process, the ...